Virtus Artificial Intelligence & Technology Opportunities Fund (AIO) |
16.63 -0.12 (-0.72%)
|
03-24 11:55 |
Open: |
16.68 |
Pre. Close: |
16.75 |
High:
|
16.8 |
Low:
|
16.53 |
Volume:
|
17,889 |
Market Cap:
|
571(M) |
|
|
Technical analysis |
as of: 2023-03-24 10:41:34 AM |
Overall:
|
|
Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
Target: |
Six months: 19.87 One year: 20.61  |
Support: |
Support1: 16 Support2: 13.31 |
Resistance: |
Resistance1: 17.01 Resistance2: 17.64  |
Pivot: |
16.74  |
Moving Average: |
MA(5): 16.69 MA(20): 16.87 
MA(100): 16.91 MA(250): 17.3  |
MACD: |
MACD(12,26): -0.2 Signal(9): -0.2  |
Stochastic oscillator: |
%K(14,3): 45.2 %D(3): 43.2  |
RSI: |
RSI(14): 47.6  |
52-week: |
High: 22.44 Low: 14.92 |
Average Vol(K): |
3-Month: 122 (K) 10-Days: 74 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ AIO ] has closed below upper band by 47.7%. Bollinger Bands are 22.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
17.06 - 17.14 |
17.14 - 17.22 |
Low:
|
16.43 - 16.53 |
16.53 - 16.61 |
Close:
|
16.6 - 16.74 |
16.74 - 16.88 |
|
Company Description |
|
Headline News |
Fri, 24 Mar 2023 Zacks Small Cap Weighs in on BioXcel Therapeutics, Inc.'s Q1 2023 ... - MarketBeat
Thu, 23 Mar 2023 Certain Virtus Closed-End Funds Announce Date of Shareholder ... - Benzinga
Fri, 17 Mar 2023 Daily AI Roundup: Biggest Machine Learning, Robotic And ... - AiThority
Thu, 16 Mar 2023 Virtus Artificial Intelligence & Technology Opportunities Fund ... - Wire19
Thu, 16 Mar 2023 AcuityAds Confirms All Monies Recovered from Silicon Valley Bank - InvestorsObserver
Sun, 12 Mar 2023 BioXcel Therapeutics (NASDAQ:BTAI) Trading Down 9.6% on ... - MarketBeat
|
Financial Analysis |
Price to Book Value: |
Neutral |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Neutral |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Neutral |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Neutral |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Neutral |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Neutral |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NYSE |
Sector: |
Industry: N/A |
Shares Out. |
34 (M) |
Shares Float |
0 (M) |
% Held by Insiders
|
0 (%) |
% Held by Institutions
|
17.6 (%) |
Shares Short
|
55 (K) |
Shares Short P.Month
|
22 (K) |
Stock Financials |
EPS
|
7.55 |
EPS Est Next Qtl
|
0 |
EPS Est This Year
|
0 |
EPS Est Next Year
|
0 |
Book Value (p.s.)
|
0 |
Profit Margin (%)
|
0 |
Operating Margin (%)
|
0 |
Return on Assets (ttm)
|
0 |
Return on Equity (ttm)
|
0 |
Qtrly Rev. Growth
|
0 |
Gross Profit (p.s.)
|
0 |
Sales Per Share
|
0 |
EBITDA (p.s.)
|
0 |
Qtrly Earnings Growth
|
0 |
Operating Cash Flow
|
0 (M) |
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
PE Ratio
|
2.22 |
PEG Ratio
|
0 |
Price to Book value
|
0 |
Price to Sales
|
0 |
Price to Cash Flow
|
0 |
Stock Dividends |
Dividend
|
0.15 |
Forward Dividend
|
0 |
Dividend Yield
|
0.8% |
Dividend Pay Date
|
2021-01-31 |
Ex-Dividend Date
|
2022-02-09 |
Your Ad Here
|
|